Blog
>
News
>
Upcoming Webinar - Cannabis Use & Employee Health: Guiding Employers on Chronic Illness and Legal Implications

Upcoming Webinar - Cannabis Use & Employee Health: Guiding Employers on Chronic Illness and Legal Implications

On August 30, 2023, after a scientific/clinical review the US Department of Health and Human Services (HHS) acknowledged that cannabis has medicinal uses and recommended rescheduling cannabis to a Class 3 drug

Learn More About EO's Products

Every EO product is clinician-designed and precisely dosed. Inhalers, gummies, tablets, tinctures, topicals, and beverage shots. They ship straight to your door, no dispensary needed.

Responsibly Made & Tested

  • ✓ 100% organic hemp, no synthetics
  • ✓ Produced at GMP-certified facilities
  • ✓ 3rd-party tested for accuracy/safety

Federally Legal

  • ✓ <0.3% hemp-derived THC
  • ✓ Farm Bill compliant
  • ✓ Ships to your door like any package

Expert Guidance Included

  • ✓ Ensure optimal dosing
  • ✓ Minimize side effects
  • ✓ Use safely and wisely
Explore

Attention HR Executives and Benefits Managers! 

‍

On August 30, 2023, after a scientific/clinical review the US Department of Health and Human Services (HHS) acknowledged that cannabis has medicinal uses and recommended rescheduling cannabis to a Class 3 drug. This means that the healthcare ecosystem, employers, health plans, and insurers must prepare for a future where cannabis is part of a benefit plan.  

Employees will be emboldened by this change to ask for coverage and now is the time to strategically prepare.  We know employees using cannabis for cancer and chronic pain abatement will be sure to ask for payment especially if they are using cannabis instead of covered drugs such as opioids.

Did you know 24% of Americans used cannabis last year? 

50% of Americans diagnosed with cancer will turn to cannabis for symptom abatement, while 

70% of oncologists did not feel equipped to make clinical recommendations regarding cannabis. 

Learn the latest trends in employee cannabis use, understand the benefits and risks, discover how employers can enhance health and business outcomes through critical illness support and employee education, and how a cannabis benefit can lower employee health care costs.

With insightful data, patient narratives, and clinical & legal expertise, this webinar equips HR professionals, benefits managers, and executives with the knowledge they need to guide their organizations in navigating the evolving landscape of cannabis use and to empower employees with responsible cannabis guidance for enhanced well-being and productivity. 

Join us on October 19th at 12:00 PM for our upcoming event: Cannabis Use & Employee Health: Guiding Employers on Chronic Illness and Legal Implications

Uncover cannabis's potential in the treatment of chronic illness with Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health. Hear a cancer survivor story from two-time cancer survivor & Survivor Africa winner Ethan Zohn. Gain an understanding of legal implications, so that you can guide your organization in the evolving cannabis landscape with Christopher Feudo, Partner Co-Chair, Labor & Employment Practice, Foley Hoag.

Don't miss out on this opportunity to learn more about cannabis wellness and potential solutions to benefit your employees and your business. 

‍

Register here>>

‍

These statements have not been evaluated by the Food and Drug Administration. This page is not intended to diagnose, mitigate, treat, cure, or prevent any disease.

Free Care Plans? Of Course.

Everyone deserves personalized, clinically responsible cannabis guidance. Tell us about your symptoms, get a plan from our clinician-led team, and message them anytime. Free, with up to 20% off the products in your plan.

Get a Free Care Plan
More
News
News

EO Care Joins the Personify Health Partner Marketplace, Expanding Employer Access to Clinically Guided Cancer Symptom Management Solution

Employers using Personify Health can choose clinically responsible, evidence-based cannabinoid care to reduce unmanaged symptom burden, prescription reliance, and avoidable healthcare costs

Read More
Read More
News

EO Data & Methodology: September 2026 Update

At EO, we systematically track how patients feel and function after starting guided cannabis care. The data below come from people living with cancer who use cannabis to manage symptoms such as pain, sleep disturbance and anxiety, under the guidance of our clinical protocols.

Read More
Read More
News

ASCO Annual Meeting 2026: Iterative Cannabis Care Plans

At the 2026 ASCO Annual Meeting, cannabinoid-based symptom management was recognized for its critical role in improving patient outcomes.

Read More
Read More